Economic note - Cost of illness studies

Economic note - Cost of illness studies
复制标题

DOI:
10.1136/bmj.320.7245.1335
复制
发表时间:
2000-05-13
影响因子:
--
通讯作者:
Raftery, J
Raftery, J
中科院分区:
医学1区
文献类型:
--
作者:
Byford, S;Torgerson, DJ;Raftery, J

文献摘要

被引文献

相似文献

疾病成本研究是医学文献中常见的一种经济学研究,特别是在专业临床期刊中。疾病成本研究的目的是确定和衡量特定疾病的所有成本,包括直接,间接和无形的方面。以货币表示的产出是对特定疾病给社会造成的总负担的估计。[1]人们普遍认为,估算一种疾病的总社会成本有助于政策决策,事实上,世界银行和世界卫生组织等组织通常使用此类研究。[2]然而,疾病成本研究一直是经济学家争论的焦点。疾病成本计算有两种方法:患病率和发病率。流行率方法是最常用的方法,用于估计某一疾病在某一年的总费用。基于发病率的方法需要更多的数据,需要计算在特定年份首次诊断的病例的终生成本,为评估新的干预措施提供基线。1
Cost of illness studies are a type of economic study common in the medical literature, particularly in specialist clinical journals. The aim of a cost of illness study is to identify and measure all the costs of a particular disease, including the direct, indirect, and intangible dimensions. The output, expressed in monetary terms, is an estimate of the total burden of a particular disease to society. 1 It is widely believed that estimating the total societal cost of an illness is a useful aid to policy decision making, and indeed organisations such as the World Bank and the World Health Organization commonly use such studies. 2 However, cost of illness studies have been the cause of much debate among economists. 1 3 4Two methods of costing illness exist—the prevalence and incidence approaches. The prevalence method is the commonest and estimates the total cost of a disease incurred in a given year. The more data hungry incidence based approach involves calculating the lifetime costs of cases first diagnosed in a particular year, providing a baseline against which new interventions can be evaluated. 1